303 related articles for article (PubMed ID: 21479966)
1. Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension.
Filusch A; Zelniker T; Baumgärtner C; Eschricht S; Frey N; Katus HA; Chorianopoulos E
Clin Res Cardiol; 2011 Oct; 100(10):879-85. PubMed ID: 21479966
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension.
Jasiewicz M; Kowal K; Kowal-Bielecka O; Knapp M; Skiepko R; Bodzenta-Lukaszyk A; Sobkowicz B; Musial WJ; Kaminski KA
Cytokine; 2014 Mar; 66(1):40-5. PubMed ID: 24548423
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.
Nickel NP; Lichtinghagen R; Golpon H; Olsson KM; Brand K; Welte T; Hoeper MM
Respir Res; 2013 Nov; 14(1):130. PubMed ID: 24251953
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
Takatsuki S; Wagner BD; Ivy DD
Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
[TBL] [Abstract][Full Text] [Related]
5. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
[TBL] [Abstract][Full Text] [Related]
6. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
[TBL] [Abstract][Full Text] [Related]
7. The significance of diminished sTWEAK and P-selectin content in platelets of patients with pulmonary arterial hypertension.
Kazimierczyk R; Błaszczak P; Kowal K; Jasiewicz M; Knapp M; Szpakowicz A; Ptaszyńska-Kopczyńska K; Sobkowicz B; Waszkiewicz E; Grzywna R; Musial WJ; Kamiński KA
Cytokine; 2018 Jul; 107():52-58. PubMed ID: 29203267
[TBL] [Abstract][Full Text] [Related]
8. The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study.
Kutsch J; Faul C; von Scheidt W; Schwaiblmair M; Berghaus TM
Respir Res; 2018 Jan; 19(1):8. PubMed ID: 29334941
[TBL] [Abstract][Full Text] [Related]
9. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
Van Albada ME; Loot FG; Fokkema R; Roofthooft MT; Berger RM
Pediatr Res; 2008 Mar; 63(3):321-7. PubMed ID: 18287971
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
[TBL] [Abstract][Full Text] [Related]
11. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
[TBL] [Abstract][Full Text] [Related]
12. Inter- not intraindividual differences in sTWEAK levels predict functional deterioration and mortality in patients with dilated cardiomyopathy.
Jarr KU; Nelles M; Katus HA; Chorianopoulos E
Mediators Inflamm; 2014; 2014():576482. PubMed ID: 25089077
[TBL] [Abstract][Full Text] [Related]
13. Assessment of right ventricular longitudinal strain by 2D speckle tracking imaging compared with RV function and hemodynamics in pulmonary hypertension.
Li Y; Wang Y; Meng X; Zhu W; Lu X
Int J Cardiovasc Imaging; 2017 Nov; 33(11):1737-1748. PubMed ID: 28553693
[TBL] [Abstract][Full Text] [Related]
14. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.
Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR
Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476
[TBL] [Abstract][Full Text] [Related]
15. Step climbing capacity in patients with pulmonary hypertension.
Fox BD; Langleben D; Hirsch A; Boutet K; Shimony A
Clin Res Cardiol; 2013 Jan; 102(1):51-61. PubMed ID: 22875547
[TBL] [Abstract][Full Text] [Related]
16. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
[TBL] [Abstract][Full Text] [Related]
17. Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome.
Chorianopoulos E; Jarr K; Steen H; Giannitsis E; Frey N; Katus HA
Atherosclerosis; 2010 Jul; 211(1):322-6. PubMed ID: 20303491
[TBL] [Abstract][Full Text] [Related]
18. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
Pudasaini B; Yang GL; Yang C; Guo J; Yuan P; Wen-Lan Y; Zhang R; Wang L; Zhao QH; Gong SG; Jiang R; Chen TX; Wei X; Liu JM
BMC Cardiovasc Disord; 2018 Mar; 18(1):56. PubMed ID: 29566672
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.
Mauritz GJ; Rizopoulos D; Groepenhoff H; Tiede H; Felix J; Eilers P; Bosboom J; Postmus PE; Westerhof N; Vonk-Noordegraaf A
Am J Cardiol; 2011 Dec; 108(11):1645-50. PubMed ID: 21890089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
